149 related articles for article (PubMed ID: 36891896)
61. Profiling of differentially expressed circRNAs and functional prediction in peripheral blood mononuclear cells from patients with rheumatoid arthritis.
Xue L; Wang B; Zhu J; He Q; Huang F; Wang W; Tao L; Wang Y; Xu N; Yang N; Jin L; Zhang H; Gao N; Lei K; Zhang Y; Xiong C; Lei J; Zhang T; Geng Y; Li M
Ann Med; 2023 Dec; 55(1):175-189. PubMed ID: 36661308
[TBL] [Abstract][Full Text] [Related]
62. Key circRNAs from goat: discovery, integrated regulatory network and their putative roles in the differentiation of intramuscular adipocytes.
Yu D; Xin L; Qing X; Hao Z; Yong W; Jiangjiang Z; Yaqiu L
BMC Genomics; 2023 Jan; 24(1):51. PubMed ID: 36707755
[TBL] [Abstract][Full Text] [Related]
63. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.
Saini KS; Loi S; de Azambuja E; Metzger-Filho O; Saini ML; Ignatiadis M; Dancey JE; Piccart-Gebhart MJ
Cancer Treat Rev; 2013 Dec; 39(8):935-46. PubMed ID: 23643661
[TBL] [Abstract][Full Text] [Related]
64. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.
Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC
Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572
[TBL] [Abstract][Full Text] [Related]
65. Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells.
Dai R; Chen R; Li H
Int J Oncol; 2009 Jun; 34(6):1749-57. PubMed ID: 19424594
[TBL] [Abstract][Full Text] [Related]
66. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response.
Sadrkhanloo M; Entezari M; Rashidi M; Hashemi M; Raesi R; Saghari S; Daneshi S; Salimimoghadam S; Hushmandi K; Mirzaei S; Taheriazam A
Eur J Pharmacol; 2022 Oct; 932():175212. PubMed ID: 36055365
[TBL] [Abstract][Full Text] [Related]
67. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives.
Asati V; Mahapatra DK; Bharti SK
Eur J Med Chem; 2016 Feb; 109():314-41. PubMed ID: 26807863
[TBL] [Abstract][Full Text] [Related]
68. Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells.
Su TR; Lin JJ; Tsai CC; Huang TK; Yang ZY; Wu MO; Zheng YQ; Su CC; Wu YJ
Int J Mol Sci; 2013 Oct; 14(10):20443-58. PubMed ID: 24129178
[TBL] [Abstract][Full Text] [Related]
69. Circular RNAs play roles in regulatory networks of cell signaling pathways in human cancers.
Almouh M; Razmara E; Bitaraf A; Ghazimoradi MH; Hassan ZM; Babashah S
Life Sci; 2022 Nov; 309():120975. PubMed ID: 36126723
[TBL] [Abstract][Full Text] [Related]
70. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
[TBL] [Abstract][Full Text] [Related]
71. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
[TBL] [Abstract][Full Text] [Related]
72. CircRNA hsa-circ-0014359 promotes glioma progression by regulating miR-153/PI3K signaling.
Shi F; Shi Z; Zhao Y; Tian J
Biochem Biophys Res Commun; 2019 Mar; 510(4):614-620. PubMed ID: 30745107
[TBL] [Abstract][Full Text] [Related]
73. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
74. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
Guenther MK; Graab U; Fulda S
Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
[TBL] [Abstract][Full Text] [Related]
75. The potential role of circular RNAs -regulated PI3K signaling in non-small cell lung cancer: Molecular insights and clinical perspective.
Kahkesh S; Khoshnazar SM; Gholinezhad Y; Esmailzadeh S; Hosseini SA; Alimohammadi M; Mafi A
Pathol Res Pract; 2024 May; 257():155316. PubMed ID: 38692125
[TBL] [Abstract][Full Text] [Related]
76. Circular RNAs: A novel target among non‑coding RNAs with potential roles in malignant tumors (Review).
Zhao W; Dong M; Pan J; Wang Y; Zhou J; Ma J; Liu S
Mol Med Rep; 2019 Oct; 20(4):3463-3474. PubMed ID: 31485661
[TBL] [Abstract][Full Text] [Related]
77. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
[TBL] [Abstract][Full Text] [Related]
78. Functions of circular RNAs in bladder, prostate and renal cell cancer (Review).
Yang L; Zou X; Zou J; Zhang G
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649838
[TBL] [Abstract][Full Text] [Related]
79. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.
Shelton JG; Steelman LS; White ER; McCubrey JA
Cell Cycle; 2004 Mar; 3(3):372-9. PubMed ID: 14726697
[TBL] [Abstract][Full Text] [Related]
80. Dual inhibition of the MEK/ERK and PI3K/AKT pathways prevents pulmonary GVHD suppressing perivenulitis and bronchiolitis.
Muranushi H; Shindo T; Chen-Yoshikawa TF; Yoshizawa A; Thi Ngo H; Gochi F; Date H; Takaori-Kondo A
Blood Adv; 2023 Jan; 7(1):106-121. PubMed ID: 35468620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
